Brain cholesterol in normal and pathological aging

被引：128
|
作者：
Martin, Mauricio [2 ,3 ]
Dotti, Carlos G. [1 ,2 ,3 ]
Dolores Ledesma, Maria [1 ]
机构：
[1] CSIC UAM, CBMSO, Madrid 28049, Spain
[2] VIB, Dept Mol & Dev Gener, B-3000 Louvain, Belgium
[3] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium
来源：
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2010年 / 1801卷 / 08期
关键词：
Cholesterol; aging; Alzheimer's disease; CYP46; brain; DENSITY-LIPOPROTEIN RECEPTOR; CENTRAL-NERVOUS-SYSTEM; APOLIPOPROTEIN-E KNOCKOUT; TRANSGENIC MOUSE MODEL; LONG-TERM POTENTIATION; E-DEFICIENT MICE; HMG-COA REDUCTASE; ALZHEIMERS-DISEASE; A-BETA; GENE-EXPRESSION;
D O I：
10.1016/j.bbalip.2010.03.011
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Correct lipid homeostasis at the plasma membrane is essential for cell survival and performance. These are critically challenged in the aging brain. Changes in the levels of cholesterol, a major membrane component especially enriched in neurons, accompany the brain aging process. They also occur in neurodegenerative diseases. Understanding the causes and consequences of these changes is a crucial step when trying to delay the cognitive decline, which comes with age, or to design strategies to fight neurodegenerative disorders such as Alzheimer's disease. We here review work that has contributed to this understanding. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码：934 / 944
页数：11
相关论文
共 50 条
  • [21] Normal patterns of regional brain 18F-FDG uptake in normal aging
    Shamchi, Sara Pourhassan
    Khosravi, Mohsen
    Taghvaei, Raheleh
    Zadeh, Mahdi Zirakchian
    Paydary, Koosha
    Emamzadehfard, Sahra
    Werner, Thomas J.
    Hoilund-Carlsen, Poul Fleming
    Alavi, Abass
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2018, 21 (03): : 175 - 180
  • [22] NEUROIMAGERY OF NORMAL AND PATHOLOGICAL CEREBRAL AGING
    VERNY, M
    GUEZ, D
    ANNALES DE MEDECINE INTERNE, 1991, 142 (04): : 269 - 274
  • [23] Normal aging in rats and pathological aging in human Alzheimer's disease decrease FAAH activity: Modulation by cannabinoid agonists
    Pascual, A. C.
    Martin-Moreno, A. M.
    Giusto, N. M.
    de Ceballos, M. L.
    Pasquare, S. J.
    EXPERIMENTAL GERONTOLOGY, 2014, 60 : 92 - 99
  • [24] Clinical neurophysiology of aging brain: From normal aging to neurodegeneration
    Rossini, Paolo M.
    Rossi, Simone
    Babiloni, Claudio
    Polich, John
    PROGRESS IN NEUROBIOLOGY, 2007, 83 (06) : 375 - 400
  • [25] Insulin resistance and pathological brain ageing
    Cholerton, B.
    Baker, L. D.
    Craft, S.
    DIABETIC MEDICINE, 2011, 28 (12) : 1463 - 1475
  • [26] Acetylome Regulation by Sirtuins in the Brain: From Normal Physiology to Aging and Pathology
    Michan, Shaday
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (38) : 6823 - 6838
  • [27] Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging
    Reiman, Eric M.
    Chen, Kewei
    Langbaum, Jessica B. S.
    Lee, Wendy
    Reschke, Cole
    Bandy, Daniel
    Alexander, Gene E.
    Caselli, Richard J.
    NEUROIMAGE, 2010, 49 (01) : 169 - 176
  • [28] Distinct Brain Regions in Physiological and Pathological Brain Aging
    Lee, Jin San
    Park, Yu Hyun
    Park, Seongbeom
    Yoon, Uicheul
    Choe, Yeongsim
    Cheon, Bo Kyoung
    Hahn, Alice
    Cho, Soo Hyun
    Kim, Seung Joo
    Kim, Jun Pyo
    Jung, Young Hee
    Park, Key-Chung
    Kim, Hee Jin
    Jang, Hyemin
    Na, Duk L.
    Seo, Sang Won
    FRONTIERS IN AGING NEUROSCIENCE, 2019, 11
  • [29] Cholesterol Metabolism in Aging and Age-Related Disorders
    Saher, Gesine
    ANNUAL REVIEW OF NEUROSCIENCE, 2023, 46 : 59 - 78
  • [30] Reelin-mediated Signaling during Normal and Pathological Forms of Aging
    Doehner, Jana
    Knuesel, Irene
    AGING AND DISEASE, 2010, 1 (01): : 12 - 29
12345